COVID-19 question set: name, symptoms, treatments, policy
A discussion answering a set question list on COVID-19: what the name stands for in medical terms, the history of its emergence in Wuhan, what China did that reduced new cases, the range of symptoms, how the virus affects the respiratory system and the rest of the body, the status of travel and testing as of May 1, preventative measures, treatments approved by the World Health Organization, the FDA or the CDC, prospects for a vaccine and warm weather, the economic fallout, and federal and state responses to affected businesses, individuals and the unemployed.
Editorial process
Last reviewed · August 13, 2026
Twelve questions, five clusters
Twelve questions run from terminology to virology to public policy to economics, and answering them at a uniform depth produces a flat post that treats defining an acronym as equivalent to explaining multi-organ pathophysiology. Weight them instead. The first question takes a sentence: COVID-19 is coronavirus disease 2019, and the causative virus is SARS-CoV-2, which is worth saying because the two are constantly conflated and getting them apart at the start signals that you know what you are doing. The questions about respiratory and systemic effects, and about which treatments carry regulatory approval, are the ones that reward real work. Group the twelve into terminology, epidemiology, clinical, policy and economic clusters, answer each cluster properly, and the post gains a structure the list does not supply. The list is not a structure, and supplying one is part of what is being assessed. Answer the terminology question first and briefly, then spend the room where it is deserved.
Two questions carry the phrase as of May 1, which fixes them to a specific moment, and this is the trap in the assignment. The travel and testing landscape then bears little resemblance to now, so if you write current information you will have answered a different question, and if you write period information without saying so you will look wrong. Handle it explicitly: state that these two answers describe the position as of the stated date, source them from material published around then, and say in a clause how the position subsequently changed. That reads as historical accuracy rather than as being out of date. The same caution applies to the warm weather question and the vaccine question, both of which have since been answered by events, and saying so is a strength rather than a digression. Being explicit about the date costs one clause and saves the whole answer.
The clinical questions have a shape worth following. The virus enters through the respiratory tract and binds a receptor that is widely distributed beyond the lung, which is the mechanism that explains why the illness was not confined to breathing. In the lungs, damage to alveolar cells and the resulting inflammatory response impair gas exchange, which is why hypoxaemia rather than obstruction is the characteristic problem and why severe cases needed oxygen and ventilation rather than bronchodilators. Beyond the lung, the documented effects include a strong tendency to clotting, cardiac involvement, kidney injury, gastrointestinal and neurological features. The severity spectrum runs from asymptomatic infection through mild illness to critical disease, and saying what proportion sat where, with a source, answers the mild-to-severe question far better than a symptom list. That mechanism is also what explains why the illness reached organs well beyond the lung. Say what proportion of infections sat in each severity band and where the figure comes from.
The treatment question is precisely worded and precision is what earns the marks: it asks what is being tried that has the approval of the World Health Organization, the FDA or the CDC, other than supportive measures. So distinguish the categories that were repeatedly muddled in public discussion. Full approval, emergency use authorisation, and recommendation within a clinical guideline are three different things with different evidentiary bases. A drug under investigation in a trial has none of them. Several agents widely discussed at the time never obtained any, and at least one authorisation was later revoked when trial evidence arrived. Naming which agents had which status, and noting that status changed as evidence accumulated, is the most substantive thing you can do here and it demonstrates the distinction the question is asking for. Getting these three categories right is the single most substantive thing available in this post.
On execution, the policy and economic questions should be answered with specifics rather than impressions: name the relief legislation, the mechanisms used for unemployment and business support, and the division between federal and state authority, which is what made responses vary so much by state. Use primary agency sources, the CDC, the FDA and the WHO, rather than news summaries, since three of the twelve questions turn on what those bodies actually said. Cite in text, and where a question has since been settled, distinguish clearly between what was known at the time and what is known now. Close by identifying which of the twelve you found hardest to answer with confident sourcing, since that invites a useful exchange with peers rather than agreement. Say which question you found hardest to source, and why the sourcing was difficult. That closing question is more useful to your peers than a summary of what you already wrote.
Likely learning objectives
Inferred from the brief — check these against your own rubric.
- 01Distinguish COVID-19 from SARS-CoV-2 correctly.
- 02Weight answers by the depth each question actually requires.
- 03Handle date-fixed questions as historical rather than current.
- 04Explain systemic effects through receptor distribution rather than by listing them.
- 05Separate full approval, emergency authorisation and guideline recommendation.
- 06Name specific relief mechanisms and the federal-state division of authority.
Read the full question
Review every instruction before using the planning guidance that follows.
Turn the brief into deliverables
- 01What COVID-19 stands for in medical terms.
- 02The history of its emergence in Wuhan and what China did that reduced new cases.
- 03The symptom range from mild to severe.
- 04How the virus affects the respiratory system and the rest of the body.
- 05The status of travel and of testing as of May 1.
- 06Preventative measures.
- 07Treatments with WHO, FDA or CDC approval, other than supportive measures.
- 08Prospects for a vaccine and the warm weather question.
- 09The economic fallout and the federal and state responses to businesses, individuals and the unemployed.
Working through the set
Terminology
COVID-19 as the disease, SARS-CoV-2 as the virus, in one precise passage.
Emergence and China's response
The Wuhan chronology, the measures that preceded the fall in new cases, and what can and cannot be inferred from the sequence.
Symptom spectrum
Mild to severe with proportions rather than a list.
Respiratory effects
Alveolar damage, inflammatory response and impaired gas exchange.
Systemic effects
Clotting, cardiac, renal, gastrointestinal and neurological involvement, and why.
Travel and testing as of May 1
The position at that date, marked as historical.
Prevention
The measures and the evidence behind each.
Treatments and their regulatory status
Approval, authorisation and recommendation kept apart, including status that later changed.
Vaccine and warm weather
What was expected then and what happened, distinguished.
Economic fallout and government response
Named relief mechanisms and the federal-state division.
Agency sources, not summaries
Recommended databases
- Centers for Disease Control and Prevention
- World Health Organization
- Food and Drug Administration authorisation records
- PubMed and NCBI Bookshelf
Search sequence
- 1.Confirm the disease and virus naming from the agency that assigned each.
- 2.Retrieve travel and testing guidance published around the stated date, not current guidance.
- 3.Check the regulatory status of each treatment individually, including any revocation.
- 4.Find severity distribution figures with a stated denominator.
- 5.Locate the relief legislation and the unemployment mechanisms by name.
Reference shortlist
These are authoritative starting points, not a ready-made bibliography. A qualified reviewer must confirm that each source fits the assignment and supports the claim beside which it is cited.
Nothing here is cleared for citation until you have read it.
- 01
COVID-19
Centers for Disease Control and Prevention · 2025
Prevention, testing and symptom guidance from the agency the question names directly.
- 02
Coronavirus disease (COVID-19) pandemic
World Health Organization · 2025
Naming, emergence chronology and the treatment recommendations the question asks about by name.
- 03
Mechanical Ventilation and Extracorporeal Membrane Oxygenation Considerations in COVID-19
StatPearls, NCBI Bookshelf · 2023
Why severe disease produced hypoxaemia requiring oxygen and ventilation, which is the respiratory mechanism question.
- 04
Postacute Coronavirus (COVID-19) Syndrome
StatPearls, NCBI Bookshelf · 2023
Multi-system involvement beyond the lung, which answers what the illness does to the rest of the body.
Review before submission
Common mistakes
- Using COVID-19 and SARS-CoV-2 interchangeably.
- Answering all twelve questions at the same depth.
- Giving current information for the questions fixed to May 1.
- Listing symptoms instead of explaining the mechanism of systemic involvement.
- Treating emergency use authorisation as equivalent to approval.
- Naming agents that never obtained any regulatory status as approved treatments.
- Answering the economic questions with impressions rather than named programmes.
- Using news summaries where the question asks what an agency said.
Submission checklist
- The disease and the virus are named separately and correctly.
- Answers are weighted rather than uniform.
- The two as of May 1 questions are answered for that date and flagged as such.
- How the position later changed is noted briefly.
- Respiratory pathophysiology explains hypoxaemia rather than obstruction.
- Systemic effects are explained through receptor distribution.
- The severity spectrum is given with proportions and a source.
- Approval, emergency authorisation and guideline recommendation are distinguished.
- At least one agent whose status later changed is identified.
- Preventative measures are stated with their evidence.
- Relief legislation and unemployment mechanisms are named.
- The federal and state division of authority is explained.
- Agency sources are cited in text.
Use this guide to plan and review your own work. Follow your institution's rules and read our academic-integrity policy.

Written by
Aaron Bishop
MA, Education
assignment interpretation and research-methods coaching across disciplines
Aaron leads the EssayCrackers editorial desk. He works on how assignment briefs are read — what a rubric is actually asking for, and where students most often answer a different question than the one set.

Reviewed by
Dr. Nathan Cole
PhD, Rhetoric & Composition
Argumentation and thesis development
Nathan teaches first-year composition and directs a university writing center. He reviews EssayCrackers guides for argumentative soundness and citation accuracy.